In 2023, the number of financing of surgical robots in the field of medical devices in China will be far ahead. According to the statistics of the medical device data cloud, among the enterprises in the field of medical device labels, there are as many as 18 financing events in the field of surgical robots.
From the perspective of the robot industry, according to incomplete statistics from China's robot network, there are more financing events in the field of medical robots than service robots, humanoid robots, drones and other fields, second only to industrial robots, and more than 100 million yuan of large financing, Wansi Medical, Surui Robot, Conoxteng, Huake Precision, Ruilong Nuofu, Banger Orthopedic Hospital Group, True Health, AVIC Chuangshi, Langhe Medical and other enterprises have completed a large financing of more than 100 million yuan.
In August 2023, the World Robot Conference will be held in Beijing. Xinhua News Agency.
Surgical robots can assist doctors in performing complex surgical procedures, and their advantages are reflected in surgical precision and surgical stability. China has a huge and unmet market demand for surgical robots; At the same time, the dividends of scientific and technological talents and engineers are outstanding; In the fields of orthopedics, vascular intervention, neurosurgery, stomatology, ophthalmology, etc., its own brands have achieved synchronous development with foreign products, and have strong competitiveness compared with international leading enterprises......These factors have contributed to the hot financing in the field of surgical robots in recent years. Yang Jianlong, deputy secretary-general of the China Association of Medical Equipment, said.
At the same time, in recent years, China has introduced a number of favorable policies related to the development of the robot industry. For example, in June 2023, 17 departments, including the Ministry of Industry and Information Technology and the National Health Commission, jointly issued the "Implementation Plan for the Application of "Robots" to encourage the development of medical robot products such as surgery, auxiliary examination, auxiliary inspection, intensive care, and **. Yang Jianlong introduced that the policy guides independent brand robots to seize strategic opportunities and promote the high-quality development of China's medical robot industry.
At present, China's medical robots are accelerating the critical period of independent innovation and clinical application promotion, the market prospect is broad, industry enterprises look forward to more support from key policies for industrial development, especially in terms of medical service pricing and medical insurance payment, I hope that the relevant national departments can balance the relationship between industrial development and medical cost control, so that China's medical robot industry can truly let go of the great development. Yang Jianlong said.